Coronary Guidewire Sales

Coronary Guidewire Sales Market Outlook

The global coronary guidewire sales market is projected to reach approximately USD 1.8 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of coronary artery diseases (CAD), the rising number of interventional cardiology procedures, and advancements in guidewire technology. Additionally, the growing geriatric population, which is more susceptible to heart ailments, fuels the demand for these medical devices. As healthcare systems globally evolve to include more minimally invasive procedures, the demand for high-performance guidewires continues to rise, impacting overall market growth positively. Furthermore, a greater emphasis on patient-centric treatment options and improvements in healthcare infrastructure are also significant contributors to this market expansion.

Growth Factor of the Market

The coronary guidewire sales market is benefiting from several key growth factors that enhance its landscape. The increasing incidence of cardiovascular diseases globally, coupled with the aging population, is driving the demand for effective diagnostic and therapeutic procedures. Moreover, the shift towards minimally invasive surgeries has prompted healthcare providers to adopt advanced guidewire technologies, thereby increasing the market share of coronary guidewires. Technological advancements, including the development of hydrophilic and coated guidewires that improve navigability and reduce the risk of injury to blood vessels, have also bolstered market growth. Additionally, an increase in healthcare spending and the availability of advanced interventional techniques are contributing to the rising demand for coronary guidewires. Furthermore, the expansion of the healthcare infrastructure in developing regions is opening new avenues for growth in this market segment.

Key Highlights of the Market

• The market is experiencing significant growth driven by rising cardiovascular diseases.
• Technological advancements in guidewire designs are enhancing procedural efficiency.
• The shift towards minimally invasive procedures is increasing the demand for coronary guidewires.
• North America holds the largest market share due to advanced healthcare infrastructure.
• Emerging economies are witnessing growth due to improved access to healthcare services.

By Product Type

Fixed Core Guidewires:

Fixed core guidewires are designed with a solid core that provides enhanced stability and torque control during procedures, making them ideal for complex interventional tasks. These guidewires are preferred in various cardiovascular procedures due to their ability to navigate through challenging anatomical structures. Their robustness allows for effective support during stent placement and balloon angioplasty, thereby enhancing procedural success rates. The increasing demand for reliable products in intricate surgeries is driving the growth of fixed core guidewires in the market. Furthermore, advancements in manufacturing techniques are leading to the production of more refined and efficient fixed core guidewires, contributing to their market penetration.

Floating Core Guidewires:

Floating core guidewires feature a unique design that allows the core to move independently within the shaft, providing increased flexibility and maneuverability. This type of guidewire is particularly advantageous in navigating tortuous vascular paths encountered during coronary interventions. The adaptability of floating core guidewires to various insertion angles reduces the risk of complications associated with rigid guidewires. The growing preference for devices that enhance procedural efficiency and patient safety is propelling the market for floating core guidewires. Additionally, continuous innovations in materials used for these guidewires are improving their performance, further solidifying their position in the coronary guidewire market.

Coated Guidewires:

Coated guidewires are designed with a special coating that enhances their lubricity, thereby reducing friction during insertion and manipulation. This feature not only facilitates smoother navigation but also minimizes the risk of vascular trauma, which is critical during delicate procedures such as angioplasty and stenting. The growing awareness among healthcare professionals about the importance of minimizing patient discomfort and improving outcomes is driving the adoption of coated guidewires in the market. Additionally, advancements in coating technologies, including hydrophilic and hydrophobic coatings, are expanding the application range of these guidewires, further fueling their demand.

Non-coated Guidewires:

Non-coated guidewires, while lacking specialized surface treatments, remain a staple in many interventional procedures due to their reliability and cost-effectiveness. These guidewires are typically made from high-strength materials such as stainless steel or nitinol and are used in various standard procedures. Their affordability compared to coated alternatives makes them an attractive option for healthcare facilities operating under budget constraints. The non-coated guidewires market is expected to retain a significant share, particularly in regions with limited access to advanced medical technologies, driving their continued relevance in the coronary guidewire sales market.

Specialty Guidewires:

Specialty guidewires are tailored for specific procedures, such as complex coronary interventions or unique anatomical challenges. These guidewires often feature advanced designs, materials, and coatings to meet the demands of specialized applications. The increasing complexity of cardiovascular surgeries and the need for customized solutions are driving the growth of the specialty guidewires segment in the market. These guidewires not only enhance procedural success rates but also improve overall patient outcomes, making them indispensable in modern interventional cardiology. As the field of cardiac intervention continues to evolve, the demand for innovative specialty guidewires is expected to rise significantly.

By Application

Percutaneous Coronary Intervention:

Percutaneous coronary intervention (PCI) is one of the most common applications for coronary guidewires, as it involves the use of guidewires to navigate through coronary arteries during procedures aimed at treating blockages. The increase in the prevalence of coronary artery diseases is fueling the demand for PCI, leading to a corresponding rise in the utilization of coronary guidewires. As interventional cardiology progresses toward more minimally invasive techniques, the importance of high-quality guidewires that can facilitate these procedures cannot be overstated. Therefore, the PCI segment is expected to dominate the application category in the coronary guidewire sales market.

Coronary Angioplasty:

Coronary angioplasty involves the use of guidewires to place a balloon catheter at the site of a narrowed artery, enabling the vessel to be widened. The efficacy of angioplasty procedures heavily relies on the performance of the guidewires used, which must be able to navigate through complex vascular paths and deliver the balloon accurately. As the global population ages and the prevalence of heart diseases increases, the demand for angioplasty procedures is on the rise. This upward trend is anticipated to contribute significantly to the overall growth of the coronary guidewire sales market, as healthcare providers continue to seek out effective solutions for treating cardiac conditions.

Coronary Artery Bypass Grafting:

Coronary artery bypass grafting (CABG) is a surgical procedure that may utilize guidewires to aid in the placement of grafts during surgery. While not as common as PCI or angioplasty, CABG still represents a significant application area for coronary guidewires. The growing incidence of severe coronary artery blockages requiring surgical intervention is maintaining the relevance of this application segment in the market. Additionally, advancements in surgical techniques and materials are enhancing the effectiveness of CABG, making the role of guidewires increasingly critical in ensuring successful outcomes.

Others:

Under the 'Others' category, various applications of coronary guidewires can be identified, including emerging and specialized procedures that may not fall under the mainstream categories. These may include uses in hybrid surgeries or in combination with other devices for complex cardiovascular interventions. The versatility of guidewires allows them to adapt to various procedures, thereby broadening their market appeal. As new interventional techniques are developed and adopted, this segment is expected to witness growth, contributing to the diversification of the coronary guidewire sales market.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for coronary guidewires, as they are the primary settings for various interventional cardiology procedures. With advanced facilities and a wide range of equipment, hospitals are equipped to handle complex surgeries that require high-quality guidewires. The increasing number of patients undergoing cardiac procedures in hospital settings is fueling the demand for guidewires, ensuring that this channel maintains a substantial market share. Furthermore, partnerships between hospitals and guidewire manufacturers are enhancing the availability and adoption of these medical devices among healthcare professionals.

Clinics:

Clinics, particularly specialized cardiology clinics, are also important distribution channels for coronary guidewires. With a growing focus on outpatient procedures, the demand for guidewires in clinic settings is on the rise. Many clinics are investing in advanced technologies to facilitate less invasive procedures, which in turn boosts the demand for high-performance guidewires. The convenience of accessing medical care at clinics, combined with the increasing prevalence of cardiovascular diseases, is making this distribution channel increasingly relevant in the coronary guidewire sales market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as significant players in the distribution of coronary guidewires, primarily due to their efficiency and cost-effectiveness in performing certain cardiac procedures. As healthcare systems focus on reducing costs while maintaining high-quality care, ASCs are becoming preferred options for outpatient surgeries. The rising number of interventional cardiology procedures performed in ASCs is contributing to the growth of this distribution channel. Furthermore, the streamlined processes and shorter recovery times associated with ASCs are enhancing their attractiveness for both patients and healthcare providers.

Online Sales:

The online sales channel is gaining traction in the coronary guidewire market, primarily due to the increasing digitization of healthcare and the rise of e-commerce. Medical professionals and healthcare facilities are increasingly turning to online platforms to procure essential medical supplies, including guidewires. This trend is driven by the convenience, competitive pricing, and access to a wider variety of products offered by online marketplaces. While regulatory challenges exist in the online sale of medical devices, the potential for growth in this channel cannot be understated, as it caters to the demand for easy access to high-quality coronary guidewires.

Others:

The 'Others' category encompasses various alternative distribution channels that may not be as prominent but still contribute to the overall sales of coronary guidewires. This can include direct sales from manufacturers to healthcare facilities, participation in medical conferences, and partnerships with distributors specializing in cardiovascular equipment. The dynamic nature of the healthcare market and the continuous evolution of distribution strategies are likely to lead to the emergence of new channels, further diversifying the landscape of coronary guidewire sales.

By Material Type

Stainless Steel:

Stainless steel is one of the most commonly used materials for manufacturing coronary guidewires due to its excellent mechanical properties, including high strength and corrosion resistance. The durability and reliability of stainless steel guidewires make them a preferred choice for many interventional procedures, ensuring optimal performance even in demanding conditions. Moreover, stainless steel guidewires offer cost-effectiveness, which appeals to healthcare facilities looking to manage expenses without compromising on quality. As awareness of the benefits of stainless steel continues to grow, this material type is expected to maintain a significant share in the coronary guidewire sales market.

Nitinol:

Nitinol, a nickel-titanium alloy, is increasingly being utilized in the production of coronary guidewires due to its unique shape memory and superelastic properties. These characteristics allow nitinol guidewires to navigate through tortuous vascular paths with ease, enhancing maneuverability during complex procedures. The ability of nitinol to return to its original shape after deformation makes it an ideal choice for interventional cardiology applications. As the demand for advanced guidewire technologies rises, nitinol's market presence is expected to grow, particularly in high-end applications requiring superior flexibility and performance.

Hybrid:

Hybrid materials, which combine different elements to enhance the performance characteristics of coronary guidewires, are gaining popularity in the market. These guidewires often feature a combination of stainless steel and nitinol or specialized coatings that provide additional benefits such as improved lubricity and reduced friction. The versatility of hybrid guidewires allows them to be tailored for specific procedures, making them an attractive option for healthcare providers looking for multifunctional solutions. As innovations in material science continue to advance, the hybrid segment is poised for significant growth in the coronary guidewire sales market.

Other Materials:

The 'Other Materials' category includes less commonly used materials in the production of coronary guidewires, such as polymer-based materials or advanced composites. These materials may be employed for specific applications where traditional materials may not suffice. The development of new materials aimed at improving guidewire performance and patient outcomes is an area of active research and innovation. As healthcare providers seek to optimize procedures, the emergence of novel materials is expected to contribute to the diversification and expansion of the coronary guidewire sales market.

By Region

The North American region dominates the coronary guidewire sales market, accounting for a significant share due to its advanced healthcare infrastructure and high prevalence of cardiovascular diseases. The region's focus on research and development, coupled with the presence of major medical device manufacturers, fosters a competitive landscape that drives innovation in coronary guidewire technology. The increasing number of percutaneous coronary interventions and angioplasty procedures in the U.S. is boosting demand for guidewires. Furthermore, the region is projected to maintain a steady growth rate of 8% CAGR during the forecast period, as healthcare providers continue to adopt advanced interventional techniques to improve patient outcomes.

In Europe, the coronary guidewire sales market is also witnessing substantial growth, driven by a rising aging population and increasing cardiovascular disease prevalence. The region's emphasis on quality healthcare services and technological advancements in medical devices significantly contributes to this growth. Countries such as Germany, France, and the UK are leading players in the European market, with a strong focus on minimally invasive procedures. The Asia Pacific region is emerging as a high-growth market, fueled by the increasing investment in healthcare infrastructure and rising awareness of cardiovascular health. While it currently holds a smaller market share, the Asia Pacific region is expected to experience rapid growth, with a projected CAGR of 9% during the forecast period, enhancing its role in the global coronary guidewire sales market.

Opportunities

The coronary guidewire sales market presents numerous opportunities for growth, particularly in developing regions where access to advanced medical technologies is expanding. As healthcare systems in countries across Asia Pacific, Latin America, and the Middle East develop, the demand for quality medical devices, including coronary guidewires, is expected to surge. Furthermore, initiatives aimed at increasing healthcare access and improving cardiovascular care in these regions are likely to drive market expansion. The increasing prevalence of lifestyle-related diseases and the growing geriatric population will further catalyze the need for effective interventional procedures, creating a favorable environment for manufacturers to introduce their products. Additionally, the rise of telemedicine and remote healthcare services presents unique opportunities for companies to reach under-served populations and expand their market presence.

Moreover, technological advancements in guidewire design and materials are opening new avenues for innovation within the market. Manufacturers focusing on developing next-generation guidewires with enhanced performance characteristics, such as hydrophilic coatings, superior torque response, and advanced imaging compatibility, will likely gain a competitive edge. The ongoing trend of minimally invasive surgeries also presents opportunities for companies to expand their product offerings and cater to the needs of healthcare professionals. Collaboration between manufacturers and healthcare providers can foster innovation, enhance product development, and improve market positioning, ultimately benefiting both parties. By capitalizing on these opportunities, stakeholders in the coronary guidewire sales market can drive growth and enhance their profitability.

Threats

Despite the promising growth prospects, the coronary guidewire sales market faces several threats that could hinder its expansion. One major challenge is the stringent regulatory landscape governing medical devices, which can increase the complexity and time required for product development and approval. Manufacturers must navigate multiple regulations across different regions, which may lead to delays in product launches and increased costs. Additionally, the market is highly competitive, with numerous players striving for market share. Intense competition often leads to price wars, potentially squeezing profit margins for manufacturers. Furthermore, the rapid pace of technological advancements necessitates continuous innovation; companies that fail to keep up with emerging trends may find it challenging to remain relevant in the market.

Another looming threat is the potential for product recalls due to quality control issues, which can significantly damage a company's reputation and customer trust. The healthcare sector is particularly sensitive to safety concerns, and any incidents related to guidewire failures can lead to legal repercussions and financial losses. Furthermore, the global COVID-19 pandemic has underscored the vulnerabilities in supply chains, with disruptions affecting the availability of raw materials and manufacturing capabilities. Such challenges could impede the growth of the coronary guidewire sales market and hinder the ability of companies to meet increasing demand.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Terumo Corporation
• Johnson & Johnson
• Cardinal Health, Inc.
• Cook Medical
• Edwards Lifesciences Corporation
• Smith & Nephew plc
• Gore Medical
• Asahi Intecc Co., Ltd.
• Biotronik SE & Co. KG
• Merit Medical Systems, Inc.
• AngioDynamics, Inc.
• Teleflex Incorporated

The competitive landscape of the coronary guidewire sales market is characterized by a mix of well-established companies and emerging players, all striving to innovate and capture market share. Major companies are focusing on research and development to enhance their product offerings, with significant investments in advanced materials and technologies. Competitive strategies such as mergers and acquisitions, partnerships, and collaborations are also prevalent as companies seek to expand their product portfolios and geographical reach. Additionally, companies are increasingly adopting customer-centric approaches by involving healthcare professionals in the design and development process, ensuring that products meet the evolving needs of interventional cardiologists and other users.

Boston Scientific Corporation and Medtronic plc are among the leading players in the coronary guidewire market, known for their extensive product lines and commitment to innovation. Boston Scientific offers a variety of guidewire options that cater to different procedural needs, emphasizing the importance of precision and reliability. Their ongoing investments in research have led to the development of advanced guidewires with enhanced navigability and minimal trauma features. Medtronic, on the other hand, leverages its vast experience in the medical device field to deliver high-quality guidewires that reflect industry standards and requirements. Their focus on integrating cutting-edge technologies within their products positions them as a formidable competitor in the market.

Abbott Laboratories and Terumo Corporation are also key players, offering a range of guidewire products designed to meet the diverse needs of healthcare providers. Abbott's commitment to patient care and safety has led to the introduction of innovative guidewire solutions that optimize procedural success. Terumo is recognized for its focus on precision and performance, with guidewires that are engineered to enhance the overall experience for both patients and healthcare professionals. The competitive dynamics are further influenced by smaller, specialized companies that seek to carve out niches with innovative products, adding complexity to the market and driving advancements in technology.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Gore Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Johnson & Johnson
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smith & Nephew plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Biotronik SE & Co. KG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Intecc Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Merit Medical Systems, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Edwards Lifesciences Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Coronary Guidewire Sales Market, By Application
    • 6.1.1 Percutaneous Coronary Intervention
    • 6.1.2 Coronary Angioplasty
    • 6.1.3 Coronary Artery Bypass Grafting
    • 6.1.4 Others
  • 6.2 Coronary Guidewire Sales Market, By Product Type
    • 6.2.1 Fixed Core Guidewires
    • 6.2.2 Floating Core Guidewires
    • 6.2.3 Coated Guidewires
    • 6.2.4 Non-coated Guidewires
    • 6.2.5 Specialty Guidewires
  • 6.3 Coronary Guidewire Sales Market, By Material Type
    • 6.3.1 Stainless Steel
    • 6.3.2 Nitinol
    • 6.3.3 Hybrid
    • 6.3.4 Other Materials
  • 6.4 Coronary Guidewire Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Sales
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Coronary Guidewire Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Coronary Guidewire Sales market is categorized based on

By Product Type

• Fixed Core Guidewires
• Floating Core Guidewires
• Coated Guidewires
• Non-coated Guidewires
• Specialty Guidewires

By Application

• Percutaneous Coronary Intervention
• Coronary Angioplasty
• Coronary Artery Bypass Grafting
• Others

By Distribution Channel

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Online Sales
• Others

By Material Type

• Stainless Steel
• Nitinol
• Hybrid
• Other Materials

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Terumo Corporation
• Johnson & Johnson
• Cardinal Health, Inc.
• Cook Medical
• Edwards Lifesciences Corporation
• Smith & Nephew plc
• Gore Medical
• Asahi Intecc Co., Ltd.
• Biotronik SE & Co. KG
• Merit Medical Systems, Inc.
• AngioDynamics, Inc.
• Teleflex Incorporated